Radiofrequency and microwave ablation in combination with transarterial chemoembolization induce equivalent histopathologic coagulation necrosis in hepatocellular carcinoma patients bridged to liver transplantation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27275464)

Published in Hepatobiliary Surg Nutr on June 01, 2016

Authors

Raj Vasnani1, Michael Ginsburg1, Osman Ahmed1, Taral Doshi1, John Hart1, Helen Te1, Thuong Gustav Van Ha1

Author Affiliations

1: 1 Department of Radiology, Section of Vascular and Interventional Radiology, 2 Department of Pathology, 3 Department of Medicine, Section of Gastroenterology, University of Chicago Medicine, Chicago, IL 60367, USA.

Articles citing this

Bridging to liver transplantation in HCC patients. Langenbecks Arch Surg (2017) 0.76

Articles cited by this

Management of hepatocellular carcinoma: an update. Hepatology (2011) 33.57

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA (2013) 20.79

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology (1999) 5.70

Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol (2012) 3.68

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol (2006) 3.65

Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology (2002) 3.16

Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer (2000) 2.59

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 2.28

Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol (2010) 1.84

Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78

Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol (2005) 1.50

Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study. J Gastrointest Surg (2007) 1.16

Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2007) 1.16

Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol (2013) 1.08

Radiofrequency ablation causes 'thermal fixation' of hepatocellular carcinoma: a post-liver transplant histopathologic study. Clin Transplant (2003) 1.07

Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma. PLoS One (2013) 1.05

Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. J Gastroenterol Hepatol (2013) 1.02

Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol (2009) 1.00

Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Intervent Radiol (2008) 0.95

Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants. Eur J Radiol (2013) 0.95

Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. World J Gastroenterol (2013) 0.92

[Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors]. Zhonghua Yi Xue Za Zhi (2011) 0.88

Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: a histopathologic study. J Vasc Interv Radiol (2014) 0.83

Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria. BMC Gastroenterol (2014) 0.82

Results of orthotopic liver transplantation for liver cirrhosis in the presence of incidental and/or undetected hepatocellular carcinoma and tumour characteristics. Transpl Int (1998) 0.81

Multimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation. Digestion (2012) 0.78

[Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations]. Zhonghua Yi Xue Za Zhi (2013) 0.77